logo
Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Yahoo24-03-2025
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bayer Aktiengesellschaft (BAYRY) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Bayer Aktiengesellschaft is one of 1011 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for BAYRY's full-year earnings has moved 5.3% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, BAYRY has gained about 33.4% so far this year. In comparison, Medical companies have returned an average of 4.4%. This means that Bayer Aktiengesellschaft is outperforming the sector as a whole this year.
Enhabit (EHAB) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 15.9%.
In Enhabit's case, the consensus EPS estimate for the current year increased 32.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, which includes 12 individual stocks and currently sits at #69 in the Zacks Industry Rank. Stocks in this group have gained about 6.3% so far this year, so BAYRY is performing better this group in terms of year-to-date returns.
On the other hand, Enhabit belongs to the Medical Services industry. This 59-stock industry is currently ranked #77. The industry has moved +5.2% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Bayer Aktiengesellschaft and Enhabit as they could maintain their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report
Enhabit, Inc. (EHAB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pentair Surpasses Q2 Earnings Estimates, Raises 2025 Guidance
Pentair Surpasses Q2 Earnings Estimates, Raises 2025 Guidance

Yahoo

time4 hours ago

  • Yahoo

Pentair Surpasses Q2 Earnings Estimates, Raises 2025 Guidance

Pentair plc PNR posted adjusted earnings per share (EPS) of $1.39 for the second quarter of 2025, which beat the Zacks Consensus Estimate of $1.33 by a margin of 4.5%. The bottom line also topped its guidance of $1.31-$1.35 and marked a 14% improvement from the prior-year quarter. Including one-time items, EPS was 90 cents compared with the prior-year quarter's $1.11. Pentair plc Price, Consensus and EPS Surprise Pentair plc price-consensus-eps-surprise-chart | Pentair plc Quote Pentair Delivers Higher Sales & Adjusted Operating Margin Net sales rose 2% year over year to $1.123 billion. The top line surpassed the Zacks Consensus Estimate of $1.115 billion. Excluding the impacts of acquisitions, divestitures and currency translation, core sales were up 1%. The cost of sales inched up 0.8% year over year to $667 million. The gross profit was $457 million, up 4.3% from the prior-year quarter. The gross margin was 40.7% compared with the year-ago quarter's 39.8%. SG&A expenses totaled $214 million, up 29.5% from the prior-year quarter's $165 million. Research and development expenses were up 1% year over year to $25 million. The operating income, including one-time items, was $217.7 million, down 12% from the year-ago quarter. Operating margin was 19.4% compared with 22.6% in the year-ago quarter. The adjusted segment operating income increased 9% year over year to $296.7 million. The adjusted segment operating margin was 26.4%, a 170-basis point expansion from the year-ago quarter. PNR's Segment Performances in Q2 Net sales in the Flow segment totaled $397 million, flat compared with the prior-year quarter. Our estimate for the segment's net sales was $407 million. Operating earnings for the segment rose 10% year over year to $93 million. Our estimate for the segment's operating profit was $89 million. Net sales in the Water Solutions segment were down 4% year over year to $298 million. The figure came in short of our estimate of $306.4 million. The segment's earnings declined 3% to $70 million and missed our projection of $73 million. Net sales in the Pool segment totaled $427 million, up 9% year over year. Our estimate for the segment's net sales was $399.6 million. Operating earnings for the segment grew 14.3% year over year to $152.7 million. Our estimate for the segment's operating income was $146.7 million. Pentair's Cash Flow & Balance Sheet Updates at Q2-End Pentair had cash and cash equivalents of around $143 million at the end of the second quarter of 2025 compared with $119 million at 2024-end. Net cash generated from operating activities was $568 million in the first half of 2025 compared with $432 million in the prior-year comparable period. The company had a long-term debt of $1.39 billion as of June 30, 2025, down from $1.64 billion as of Dec. 31, had hiked its dividend by 9% to 25 cents per share earlier this year. This marked the 49th consecutive year that the company has increased its dividend. Pentair has repurchased 1.3 million of its shares for $125 million so far in 2025. As of June 30, 2025, the company had $325 million available under its share repurchase authorization. PNR's Guidance for Q3 & 2025 Backed by the upbeat performance so far this year, Pentair expects adjusted EPS to be in the range of $4.75- $4.85 for 2025, higher than its previous guidance of $4.65-$4.80. The mid-point of the range indicates year-over-year growth of 9.1%. The company has also raised its year-over-year reported sales growth guidance to 1-2% for 2025. Earlier, sales were expected to be flat or increase 2% on a reported basis from the 2024 level. For the third quarter, the company expects an adjusted EPS between $1.16 and $1.20, implying an 8% rise at the midpoint. Pentair anticipates the quarter's sales to be flat to up 1% from the year-ago quarter's figure. Pentair Stock's Price Performance Pentair stock has gained 20.3% over the past year compared with the industry's 4.2% growth. Image Source: Zacks Investment Research PNR's Zacks Rank Pentair currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Pentair's Peers Awaiting Results Pool Corp. POOL is expected to release second-quarter 2025 results on July 24, 2025. The Zacks Consensus Estimate for POOL's earnings is pegged at $5.13 per share, indicating year-over-year growth of 3%. The estimate for Pool Corp.'s top line is pegged at $1.79 billion, implying an increase of 1.2% from the prior year's figure. POOL has a trailing four-quarter average earnings surprise of 1.17%. Xylem XYL, scheduled to release second-quarter 2024 results on July 31, has a trailing four-quarter average earnings surprise of 4.15%. The Zacks Consensus Estimate for Xylem's earnings for the quarter is pegged at $1.14 per share, implying year-over-year growth of 4.6%.The consensus estimate for Xylem's top line is pegged at $2.21 billion, indicating a rise of 2% from the prior-year figure. Ecolab ECL is scheduled to report second-quarter 2025 results on July 29. The Zacks Consensus Estimate for earnings is pegged at $1.90 per share, implying a 13% increase from the prior-year figure. The estimate for Ecolab's revenues for the quarter is $4.01 billion, indicating a 0.6% increase from the year-ago quarter. The company has an average earnings surprise of 0.7% in the past four quarters. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL) : Free Stock Analysis Report Pool Corporation (POOL) : Free Stock Analysis Report Pentair plc (PNR) : Free Stock Analysis Report Xylem Inc. (XYL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

UMB Financial (UMBF) Earnings Expected to Grow: Should You Buy?
UMB Financial (UMBF) Earnings Expected to Grow: Should You Buy?

Yahoo

time4 hours ago

  • Yahoo

UMB Financial (UMBF) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when UMB Financial (UMBF) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on July 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus Estimate This bank holding company is expected to post quarterly earnings of $2.37 per share in its upcoming report, which represents a year-over-year change of +9.7%. Revenues are expected to be $637.07 million, up 60.7% from the year-ago quarter. Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 2.02% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Earnings Whisper Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for UMB? For UMB, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -2.37%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination makes it difficult to conclusively predict that UMB will beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue? While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that UMB would post earnings of $2.21 per share when it actually produced earnings of $2.58, delivering a surprise of +16.74%. Over the last four quarters, the company has beaten consensus EPS estimates four times. Bottom Line An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. UMB doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. An Industry Player's Expected Results Among the stocks in the Zacks Banks - Midwest industry, Enterprise Financial Services (EFSC), is soon expected to post earnings of $1.2 per share for the quarter ended June 2025. This estimate indicates a year-over-year change of -0.8%. This quarter's revenue is expected to be $163.2 million, up 4.6% from the year-ago quarter. Over the last 30 days, the consensus EPS estimate for Enterprise Financial Services has remained unchanged. Nevertheless, the company now has an Earnings ESP of -0.56%, reflecting a lower Most Accurate Estimate. When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that Enterprise Financial Services will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UMB Financial Corporation (UMBF) : Free Stock Analysis Report Enterprise Financial Services Corporation (EFSC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Earnings Preview: Werner Enterprises (WERN) Q2 Earnings Expected to Decline
Earnings Preview: Werner Enterprises (WERN) Q2 Earnings Expected to Decline

Yahoo

time4 hours ago

  • Yahoo

Earnings Preview: Werner Enterprises (WERN) Q2 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on lower revenues when Werner Enterprises (WERN) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 29. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus Estimate This transportation company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of -70.6%. Revenues are expected to be $736.75 million, down 3.2% from the year-ago quarter. Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 17.83% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings Whisper Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Werner? For Werner, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +45.71%. On the other hand, the stock currently carries a Zacks Rank of #4. So, this combination makes it difficult to conclusively predict that Werner will beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue? Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Werner would post earnings of $0.12 per share when it actually produced a loss of -$0.12, delivering a surprise of -200.00%. The company has not been able to beat consensus EPS estimates in any of the last four quarters. Bottom Line An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Werner doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Werner Enterprises, Inc. (WERN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store